Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoingin vitrofertilization

Item

http://www.wikidata.org/entity/Q58323742

description

article

@en

im Februar 2006 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2006

@uk

name

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@en

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@nl

type

Item

label

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@en

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@nl

prefLabel

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@en

Effect of gonadotropin-releasi ...... ndergoingin vitrofertilization

@nl

P1476

Effect of gonadotropin-releasi ...... ergoing in vitro fertilization

@en

P2093

Kamel Abdelhakim Mohamed

http://www.w3.org/2001/XMLSchema#string

William A R Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone.

Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report.

Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited.

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction.

Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis.

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial.

P304

57-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590500519260

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hany Lashen

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16603428

http://www.w3.org/2001/XMLSchema#string